SRPX2 inhibitors belong to a specialized class of chemical compounds designed to target and modulate the activity of SRPX2, also known as Sushi Repeat-containing Protein X-linked 2. SRPX2 is a protein that contains sushi repeat domains, which are characteristic protein-protein interaction modules often found in cell adhesion proteins and extracellular matrix components. While the precise functions of SRPX2 are still under investigation, it has been implicated in various biological processes, including neuronal development, synaptic plasticity, and potentially cell adhesion. Inhibitors of SRPX2 are developed to interact with this specific protein, potentially influencing its interactions with binding partners, cellular localization, or participation in cellular processes where SRPX2 is involved.
Structurally, SRPX2 inhibitors are designed to engage specific regions or binding sites on the SRPX2 protein. This interaction may disrupt the normal functioning of SRPX2, potentially affecting its ability to mediate protein-protein interactions or other molecular functions. The mechanisms by which SRPX2 inhibitors exert their effects can vary, but their primary objective is to serve as valuable tools for researchers studying the roles of SRPX2 in various biological contexts. Investigating the biochemical and functional aspects of SRPX2 and its modulation by inhibitors can contribute to a deeper understanding of neuronal development, synaptic plasticity, cell adhesion, and the broader field of molecular and cellular biology, ultimately offering insights into the intricate molecular mechanisms governing fundamental cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus is an mTOR inhibitor. As mTOR can regulate protein synthesis and cell growth, it may indirectly influence SRPX2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A potent inhibitor of phosphatidylinositol 3-kinase (PI3K). PI3K signaling could be involved in regulating SRPX2 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, wortmannin can influence various signaling pathways that might indirectly affect SRPX2 levels. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
A flavonoid that has been reported to influence various signaling pathways and might have an effect on SRPX2 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
An inhibitor of tyrosine kinases that might indirectly influence SRPX2 expression via tyrosine kinase-related pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MEK, which is upstream of ERK in the MAPK pathway. This pathway might play a role in SRPX2 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, a kinase in the MAPK pathway. Potential regulation of SRPX2 expression through this pathway. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
An inhibitor of glycolysis that can influence various cellular processes and might indirectly affect SRPX2 expression. | ||||||
PX-866 | 502632-66-8 | sc-396764 sc-396764A | 1 mg 5 mg | $146.00 $282.00 | ||
A PI3K inhibitor that can potentially affect SRPX2 expression by modulating PI3K-dependent signaling pathways. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
An AKT inhibitor. Since AKT is a downstream target of PI3K, its inhibition could potentially regulate SRPX2 expression. | ||||||